CAS 101470-23-9

Formule : C13H19NO

InChI : InChI=1S/C13H19NO/c1-2-8-14-11-6-7-12-10(9-11)4-3-5-13(12)15/h3-5,11,14-15H,2,6-9H2,1H3/t11-/m0/s1

Code InChI : VCYPZWCFSAHTQT-NSHDSACASA-N

SMILES : CCCN[C@H]1CCC2=C(C1)C=CC=C2O

(S)-6-(Propylamino)-5,6,7,8-tetrahydronaphthalen-1-ol

CAS : 101470-23-9

(S)-6-(Propylamino)-5,6,7,8-tetrahydronaphthalen-1-ol

Degré de pureté : 95+%

Masse moléculaire : 205.3009949

Ref: 10-F910922

Rotigotine EP Impurity B

CAS : 101470-23-9

Formule : C₁₃H₁₉NO

Masse moléculaire : 205.30

Ref: ST-EA-CP-R51002

(6S)-5,6,7,8-Tetrahydro-6-(propylamino)-1-naphthalenol

Produit contrôlé

CAS : 101470-23-9

Rotigotine is a drug that is used to treat Parkinson's disease. It is a dopamine agonist that stimulates the release of dopamine in the brain. Rotigotine has been shown to be effective in controlling symptoms of Parkinson's disease, such as tremors and stiffness, and improving motor skills. This drug has also been shown to have a good tolerability profile, with few side effects reported. Rotigotine is rapidly absorbed from the gastrointestinal tract and metabolized by CYP2D6 into desalkyl rotigotine, which are pharmacologically inactive compounds. The mean terminal half-life for rotigotine is about 2 hours.

Formule : C₁₃H₁₉NO

Degré de pureté : Min. 95%

Masse moléculaire : 205.3 g/mol

Ref: 3D-FT28115

(S)-6-(Propylamino)-5,6,7,8-tetrahydronaphthalen-1-ol

CAS : 101470-23-9

Formule : C₁₃H₁₉NO

Masse moléculaire : 205.2961

Ref: IN-DA0004K5